Development of High-Throughput Screening Assays for Inhibitors of ETS Transcription Factors

Simon L Currie1, Steven L Warner2,3, Hariprasad Vankayalapati2,4

  • 11 Department of Oncological Sciences, School of Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

Insights

We developed new high-throughput screening assays to find drugs targeting ETS transcription factors, which drive prostate cancer progression. These assays successfully identified compounds inhibiting key ETS factors like ERG and ETV1, offering new therapeutic avenues.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Drug Discovery

Background:

  • ETS transcription factors, including ERG and ETV1/4/5, are frequently overexpressed in prostate cancer.
  • These overexpressed factors play a significant role in the progression of prostate cancer.
  • Targeting these ETS factors presents a potential therapeutic strategy.

Purpose of the Study:

  • To develop novel in vitro assays for high-throughput screening of ETS transcription factor-DNA interactions.
  • To identify compounds that inhibit the activity of ETS transcription factors implicated in prostate cancer.

Main Methods:

  • Development of two high-throughput screening assays to measure ETS transcription factor-DNA binding.
  • Screening of 110 compounds using ETS1 as a model, with a focus on lower-affinity DNA binding sequences.
  • Validation of assay robustness for ERG, ETV1, and ETV5, key ETS factors in prostate cancer.

Main Results:

  • The developed in vitro assays are suitable for high-throughput screening.
  • Using lower-affinity DNA binding sequences enhanced compound inhibition, mimicking binding sites of ERG and ETV1 in prostate cells.
  • The assays demonstrated robustness for multiple ETS transcription factors (ERG, ETV1, ETV5) overexpressed in prostate cancer.

Conclusions:

  • Novel high-throughput screening assays for ETS transcription factor-DNA interactions have been successfully developed.
  • These assays facilitate the identification of inhibitors targeting ETS factors crucial for prostate cancer progression.
  • The findings support the development of targeted therapies for prostate cancer by inhibiting specific ETS transcription factors.

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.8K
Transcription Elongation Factors02:35

Transcription Elongation Factors

Transcription elongation is a dynamic process that alters depending upon the sequence heterogeneity of the DNA being transcribed. Hence, it is not surprising that the elongation complex's composition also varies along the way while transcribing a gene.
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
14.0K
Transcription Elongation Factors02:35

Transcription Elongation Factors

4.8K
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
7.1K
Transcription01:10

Transcription

Overview
Transcription is the process of synthesizing RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in the proper synthesis of messenger RNA (mRNA). Regulation of transcription is responsible for the differentiation of all the different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds...
156.7K